The Polycomb repressive complexes (PRC) regulate self-renewal and differentiation in embryonic stem cells (ESCs) . In this issue of Cell Stem Cell, Morey et al. (2012) and O'Loghlen et al. (2012) report that dynamic interchange of PRC subunits modulates the balance between self-renewal and lineage commitment in ESCs.
Differentiate or self-renew? This is the principal question faced by all stem cells. The self-renewal of embryonic stem cells (ESCs) is maintained through expression of pluripotency genes and repression of lineage-specific genes. Conversely, differentiation is achieved through repression of the genes required for pluripotency, with simultaneous activation of a cascade of lineage-specific epigenetic and transcriptional changes. First identified in Drosophila, the Polycomb group (PcG) proteins are known regulators of ESC differentiation and do so by maintaining repressive chromatin states. The mammalian genome encodes multiple homologs of PcG components which broadly associate in two functionally distinct complexes, PRC1 and PRC2. PRC2 has been shown to functionally trimethylate lysine 27 on histone H3 (H3K27me3), while PRC1 monoubiquitylates histone H2A on lysine 119 (H2AK119Ub1) (Cao and Zhang, 2004; de Napoles et al., 2004) . The prevailing dogma posits PRC2 and PRC1 work as a team to prevent transcription of genes that initiate differentiation. Mechanistically this is thought to occur via a PRC2-mediated deposition of H3K27me3 followed by H2AK119Ub1 catalyzed by PRC1 specifically at these sites. In pluripotent cells, PRC1/PRC2 co-occupy regions which overlap with H3K27me3, and a large proportion of these sites are proximal to genes involved in development and lineage commitment (Ku et al., 2008) . Additionally, loss of function of either PRC1 or PRC2 in pluripotent cells does not affect expression of key pluripotency genes, but rather leads to derepression of genes normally upregulated during differentiation (Chamberlain et al., 2008; Leeb and Wutz, 2007) .
Although PRC1 functionally targets PRC2 modified chromatin, it is unclear how PRC1 identifies sites of PRC2 catalyzed H3K27me3 and what regulatory mechanisms exist to facilitate derepression of PcG bound chromatin in response to ESC differentiation. Unlike PRC2, the PRC1 complex has been shown to contain a number of Polycomb orthologs (PCs) known as the Cbx family of proteins. Cbx proteins have been shown to interact directly with methylated histone H3 and are enriched at sites of heterochromatin (Bernstein et al., 2006 (Figure 1) .
Further, ChIP with pluripotent cells revealed strong association of Cbx7/ PRC1 localization to Cbx2, Cbx4, and Cbx8, concomitant with transcriptional repression of these genes (Morey et al., 2012, and O'Loghlen et al., 2012) . Notably, both Cbx7 and PRC1 localization to chromatin is completely dependent on PRC2-mediated H3K27me3 (Morey et al., 2012 (Morey et al., 2012) . Additionally, O'Loghlen et al. observed that Cbx7 and Cbx8 had reciprocal binding patterns at promoters in ESCs versus differentiated cells. Taken together these data point to a dynamic mechanism by which the PCR1 complex exchanges Cbx7 for Cbx2, 4, or 8 during differentiation.
Building on these results, O'Loghlen et al. sought to identify the mechanism for Cbx7 downregulation upon differentiation. Citing a recent study which identified micro RNAs (miRs) as regulators of ESC differentiation (Melton and Blelloch, 2010) , the authors cleverly utilized a miR expression library to identify two putative miRs (miR-125, miR-181) which downregulated a Cbx7-reporter construct. When overexpressed in fibroblasts, these miRs decreased Cbx7 transcript levels and induced senescence, a phenotype , 4, and 8. Cbx2, 4 , and 8 interact with PRC1, forming new repressive complexes. These ''differentiation-specific'' PRC1 complexes downregulate expression of pluripotency genes, as well as Cbx7, contributing to a PcG autoregulatory mechanism to further suppress self-renewal and guide the cell toward lineage commitment.
previously associated with shRNA-mediated knockdown of Cbx7 (Gil et al., 2004) . Strikingly, when expressed in ESCs, miR-125 and miR-181 downregulated Cbx7 expression and promoted differentiation, providing direct evidence that miR regulation of PcG proteins is a determining factor in maintenance of self-renewal in pluripotent cells. In their final experiment Morey et al. demonstrate that ESCs depleted of Cbx7, Cbx4, and Cbx2 can form teratomas in vivo. This was not entirely unexpected considering previous work has shown that teratomas can be formed even in the absence of PRC1 (Leeb et al., 2010) . The authors assert that the teratoma formation is skewed toward the ectodermal lineage for grafts depleted of Cbx7 and the endodermal and mesodermal lineage for grafts depleted Cbx2 and Cbx4. Although this in vivo data is somewhat qualitative, it is consistent with expression data from Cbx7, Cbx2, and Cbx4 knockdowns. The role of the Cbx/ PRC1 complex specificity as it relates to differentiation into the three germs layers needs to be further explored both in vitro and in vivo. Another interesting question not addressed in either paper is how PcG complexes are regulated when differentiated cells are returned to a pluripotent state using iPS technology. It would be interesting and informative to see if Cbx7/PRC1 complexes are reformed with a return to pluripotency and if these complexes function to transcriptionally re-repress Cbx2, 4, and 8. Nonetheless, these reports mark a significant step toward understanding how PcG proteins are regulated in ESCs and how this regulation helps modulate the fine balance between self-renewal and differentiation in pluripotent cells.
